neramexane: Clinical Trials

7 completed. 7 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	7	Completed 7

Follow neramexane: new trials by email Literature Review of neramexane trials Research Report on neramexane

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects Neramexane - Metabolism of Neramexane	Phase 1	Completed	Merz Pharmaceuticals GmbH	8	2010-04-01	2011-02-08
Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification Regimen Neramexane - Healthy	Phase 1	Completed	Merz Pharmaceuticals GmbH		2009-10-01	2011-02-07
Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects Neramexane - Healthy	Phase 1	Completed	Merz Pharmaceuticals GmbH	56	2009-09-01	2011-04-15
Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult Subjects Neramexane - Healthy Subjects	Phase 1	Completed	Merz Pharmaceuticals GmbH	126	2009-09-01	2011-02-15
Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate Neramexane - Healthy	Phase 1	Completed	Merz Pharmaceuticals GmbH		2009-08-01	2011-02-08
Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane Neramexane - Healthy Subjects	Phase 1	Completed	Merz Pharmaceuticals GmbH		2009-07-01	2011-02-08
Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects Neramexane - Healthy	Phase 1	Completed	Merz Pharmaceuticals GmbH	36	2009-06-01	2011-05-06

Sponsors

Merz Pharmaceuticals GmbH (7)

Countries

Germany (4)  ·  Belgium (1)  ·  United States (1)